Molecule Details
InChIKeyYREYEVIYCVEVJK-UHFFFAOYSA-N
Compound NameRabeprazole
Canonical SMILESCOCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)6
Pfam Stratification Cross-Family
Avg pChEMBL6.32
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB01129
Drug NameRabeprazole
CAS Number117976-89-3
Groups approved investigational
ATC Codes A02BD12 A02BD13 A02BC54 A02BC04
DescriptionRabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastri...

Categories: 2-Pyridinylmethylsulfinylbenzimidazoles Acetates Acid Reducers Acids, Acyclic Alimentary Tract and Metabolism Anti-Ulcer Agents Antiinflammatory Preparations, Non-Steroids for Topical Use Antiinflammatory and Antirheumatic Products Antiinflammatory and Antirheumatic Products, Non-Steroids BCRP/ABCG2 Inhibitors Benzimidazoles Butylpyrazolidines Cytochrome P-450 CYP1A2 Inducers Cytochrome P-450 CYP1A2 Inducers (strength unknown) Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C19 inhibitors (strength unknown) Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (moderate) Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (strength unknown) Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (weak) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs for Acid Related Disorders Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord) Drugs that are Mainly Renally Excreted Enzyme Inhibitors Gastric Acid Lowering Agents Gastrointestinal Agents Heterocyclic Compounds, Fused-Ring Hydroxy Acids Musculo-Skeletal System Proton Pump Inhibitors Proton-pump Inhibitors Pyrazoles Pyrazolones Pyridines Sulfoxides Sulfur Compounds Topical Products for Joint and Muscular Pain
Cross-references: BindingDB: 651963 ChEBI: 8768 CHEMBL1219 ChemSpider: 4853 Drugs Product Database (DPD): 12149 C07864 D08463 PharmGKB: PA451216 PubChem:5029 PubChem:46506366 RxCUI: 114979 Therapeutic Targets Database: DAP000727 Wikipedia: Rabeprazole
Target Activities (6)
Target Gene Organism Category Pfam pChEMBL Type Source
P61964 WDR5 Homo sapiens Human PF25175 6.3 IC50 ChEMBL
Q03164 KMT2A Homo sapiens Human PF05965 PF05964 PF00628 PF00856 PF02008 PF13771 6.3 IC50 ChEMBL
P18089 ADRA2B Homo sapiens Human PF00001 6.1 Ki ChEMBL
P35462 DRD3 Homo sapiens Human PF00001 6.1 Ki ChEMBL
P14916 ureA Helicobacter pylori (strain ATCC 700392 / 26695) Pathogen PF00699 PF00547 6.5 IC50 ChEMBL
P69996 ureB Helicobacter pylori (strain ATCC 700392 / 26695) Pathogen PF01979 PF00449 6.5 IC50 ChEMBL;BindingDB
DrugBank Target Actions (12)
Target Gene Target Name Action Type
P04798 CYP1A1 Cytochrome P450 1A1 inducer enzymes
P05177 CYP1A2 Cytochrome P450 1A2 inducer enzymes
P05177 CYP1A2 Cytochrome P450 1A2 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P10632 CYP2C8 Cytochrome P450 2C8 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P11712 CYP2C9 Cytochrome P450 2C9 inhibitor enzymes
P33261 CYP2C19 Cytochrome P450 2C19 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
P20648 ATP4A Potassium-transporting ATPase alpha chain 1 inhibitor targets
Q9UNQ0 ABCG2 Broad substrate specificity ATP-binding cassette transporter ABCG2 inhibitor transporters